Product image of Jentadueto (Metformin Hydrochloride, Linagliptin) supplied by GNH India

Jentadueto

Active Ingredient:
Metformin Hydrochloride, Linagliptin
Origin:
EU

Jentadueto (Metformin Hydrochloride, Linagliptin)

Metformin Hydrochloride and Linagliptin, the active ingredients in Jentadueto, are a biguanide and a DPP‑4 inhibitor presented as a tablet for oral use. They are indicated for the management of type 2 diabetes mellitus as an adjunct to diet and exercise in adult patients.

GNH India supplies Jentadueto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured for the EU market under strict regulatory standards, ensuring consistent potency and safety throughout the supply chain.

Manufacturer / TM Owner

Boehringer Ingelheim International Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Jentadueto is used in the management of type 2 diabetes mellitus, targeting glucose regulation pathways.
  • Type 2 diabetes mellitus: improves overall glycemic control when added to diet and exercise.
  • Inadequate response to metformin alone: provides additional glucose‑lowering effect through DPP‑4 inhibition.
  • Combination therapy: reduces HbA1c levels more effectively than either component alone.

How It Works

  • Metformin Hydrochloride reduces hepatic gluconeogenesis and enhances peripheral insulin sensitivity, while Linagliptin selectively inhibits dipeptidyl peptidase‑4, leading to increased endogenous incretin hormones (GLP‑1 and GIP). The elevated incretins promote glucose‑dependent insulin secretion and suppress glucagon release, together achieving better blood glucose regulation.

Side Effects

Jentadueto may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, often transient.
  • Abdominal discomfort: cramping or pain.
  • Headache: mild tension‑type headaches.
  • Nasopharyngitis: upper respiratory tract infection symptoms.
  • Dizziness: occasional light‑headedness.

Serious or Rare Side Effects

  • Lactic acidosis: rare but life‑threatening metabolic disturbance.
  • Severe hypoglycemia: especially when combined with insulin or sulfonylureas.
  • Pancreatitis: acute inflammation of the pancreas.
  • Severe allergic reactions: rash, angioedema, or anaphylaxis.
  • Hepatic dysfunction: abnormal liver enzymes or liver injury.
  • Renal impairment worsening: may exacerbate kidney function decline.

Precautions & Warnings

  • Before prescribing Jentadueto, clinicians should evaluate patient-specific factors and monitor for potential complications.
  • Renal function: assess creatinine clearance before initiating and periodically monitor.
  • Hepatic impairment: use with caution; avoid in severe hepatic disease.
  • Risk of lactic acidosis: contraindicated in conditions predisposing to hypoxia.
  • Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks.
  • Drug interactions: review concomitant medications that affect renal clearance or increase hypoglycemia risk.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Jentadueto can interact with several medicines, requiring careful management to avoid adverse outcomes.

Major Interactions (Avoid)

  • Intravenous contrast agents in patients with renal impairment: increased risk of metformin‑associated lactic acidosis.
  • Combination with insulin or sulfonylureas: heightened risk of hypoglycemia.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise linagliptin plasma levels.

Moderate Interactions (Monitor Closely)

  • Diuretics (e.g., thiazides): may affect renal function and metformin clearance.
  • ACE inhibitors or ARBs: monitor renal function and serum potassium.
  • Excessive alcohol intake: can potentiate metformin's effect on lactate metabolism.

Frequently Asked Questions

Jentadueto is prescribed for adults with type 2 diabetes mellitus to improve blood glucose control when used together with diet and exercise. It combines metformin, which lowers hepatic glucose output, and linagliptin, which enhances insulin secretion through incretin pathways.

Metformin Hydrochloride primarily reduces the liver’s production of glucose and increases the sensitivity of muscle cells to insulin, facilitating greater glucose uptake from the bloodstream. This dual action helps lower fasting and post‑prandial blood sugar levels.

The dosage of Jentadueto is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Jentadueto in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Jentadueto product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Jentadueto combines two mechanisms—biguanide action of metformin and DPP‑4 inhibition of linagliptin—offering complementary glucose‑lowering effects. Compared with monotherapy agents, the combination can achieve greater HbA1c reduction without the need for multiple separate tablets, potentially improving adherence.

Jentadueto tablets should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Jentadueto is taken orally, usually once daily with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a full glass of water and not crushed or chewed.

The most serious risks include lactic acidosis, a rare but potentially fatal metabolic condition, and severe hypoglycemia, especially when used with insulin or sulfonylureas. Patients should be educated on recognizing early symptoms and seek immediate medical attention if they occur.

Jentadueto is contraindicated in patients with severe renal impairment, significant hepatic disease, a history of lactic acidosis, or known hypersensitivity to metformin, linagliptin, or any of the tablet’s excipients. Clinicians should assess each patient’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride, Linagliptin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT